Literature DB >> 8866036

Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin.

Z Wachol-Drewek1, M Pfeiffer, E Scholl.   

Abstract

Collagen implants of various structures and a gelatine sponge were placed in five different antibiotic solutions until complete saturation occurred. The antibiotics were chosen to represent different drug classes (gentamicin sulphate, cefotaxim, fusidic acid, clindamycin, vancomycin). The collagen implants saturated with antibiotic solution and a lyophilized collagen sponge containing gentamicin sulphate were eluated in 0.066 M phosphate buffer (pH = 7.4) at 37 degrees C. The total eluation period is 7 d with buffer changes every 24 h. The antibiotic delivery by the collagen implants and the lyophilized sponge containing gentamicin sulphate is complete after a maximum of 4 d. If an implant that has a protective effect against wound infections over a period of 24-48 h is required, the materials described here are suitable. However, where treatment in infected areas should ensure antibiotic cover for 5-10 d, neither collagen materials immersed in antibiotic solutions nor collagen sponges containing gentamicin are suitable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866036     DOI: 10.1016/0142-9612(96)87654-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  Gentamicin-Loaded Polysaccharide Membranes for Prevention and Treatment of Post-operative Wound Infections in the Skeletal System.

Authors:  Urszula Cibor; Małgorzata Krok-Borkowicz; Monika Brzychczy-Włoch; Łucja Rumian; Krzysztof Pietryga; Dominika Kulig; Wojciech Chrzanowski; Elżbieta Pamuła
Journal:  Pharm Res       Date:  2017-06-21       Impact factor: 4.200

Review 2.  Review collagen-based biomaterials for wound healing.

Authors:  Sayani Chattopadhyay; Ronald T Raines
Journal:  Biopolymers       Date:  2014-08       Impact factor: 2.505

Review 3.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

Review 4.  Implantable antimicrobial biomaterials for local drug delivery in bone infection models.

Authors:  Jeremy D Caplin; Andrés J García
Journal:  Acta Biomater       Date:  2019-01-14       Impact factor: 8.947

Review 5.  Carrier systems for the local delivery of antibiotics in bone infections.

Authors:  K Kanellakopoulou; E J Giamarellos-Bourboulis
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

Review 6.  Immobilized antibiotics to prevent orthopaedic implant infections.

Authors:  Noreen J Hickok; Irving M Shapiro
Journal:  Adv Drug Deliv Rev       Date:  2012-04-04       Impact factor: 15.470

7.  The possibility of using fibrin-based collagen as an antibiotic delivery system.

Authors:  Junichi Nishimura; Kiyokazu Nakajima; Yoshihito Souma; Tsuyoshi Takahashi; Naoki Ikeguchi; Rei Takenaka; Naoki Shinohara; Toshirou Nishida; Yuichiro Doki; Masaki Mori
Journal:  Surg Today       Date:  2012-06-01       Impact factor: 2.549

8.  In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship.

Authors:  S Lin; P Y Chao; Y W Chien; S Sayani; S Kuma; M Mason; T Wes; A Yang; D Monkhouse
Journal:  AAPS PharmSciTech       Date:  2001-09-21       Impact factor: 3.246

9.  Antibiotic-impregnated bone grafts in orthopaedic and trauma surgery: a systematic review of the literature.

Authors:  Konstantinos Anagnostakos; Katrin Schröder
Journal:  Int J Biomater       Date:  2012-07-26

10.  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial.

Authors:  Petra Baumann; Hardy Schumacher; Johannes Hüsing; Steffen Luntz; Hanns-Peter Knaebel
Journal:  Trials       Date:  2009-09-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.